Skip to main content
. 2013 Aug 12;13:106. doi: 10.1186/1471-2377-13-106

Figure 5.

Figure 5

Additional effects of levosimendan treatment on neurological injury during MCAO. Differences between groups for brain swelling (A), serum levels of s-100ß (B) and neurological testing (C) after 24 hours were displayed (* p <0.05 vs. control; ** p < 0.01 vs. control).